Want to track 0HD2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
0HD2 earnings report is expected in 64 days (29 Apr 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
 | | 1.59 | - |
| | | - | - |
| | | 1.5 | 1.37 |
| | | - | - |
| | | - | - |
| | | - | - |
0HD2 Earnings Reports FAQ
What is the earnings per share (EPS) for 0HD2?
The current EPS is -3.56.
What is the company's earnings growth rate?
Alnylam Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-04-29, based on the 0HD2's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 1.3679 per share, reported on 2026-02-12. For dividend history, visit the 0HD2 Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 241.25, calculated based on the most recent stock price of $330.00.
